查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2102592

獸用疫苗市場：預測至2034年－全球分析（依動物種類、疫苗類型、目標疾病、給藥途徑、通路、最終使用者、技術平台、病原體類型和地區分類）

Veterinary Vaccines Market Forecasts to 2034 - Global Analysis By Animal Type, Vaccine Type, Disease Indication, Route of Administration, Distribution Channel, End User, Technology Platform, Pathogen Type, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球獸用疫苗市場規模將達到 139 億美元，並在預測期內以 7.8% 的複合年成長率成長，到 2034 年將達到 254 億美元。

獸用疫苗是用於動物的生物製藥，旨在刺激動物對特定病原體的免疫反應，從而保護其感染疾病。這些疫苗可透過多種途徑接種，包括注射、口服、鼻內、眼內和噴霧接種，適用於各種寵物和牲畜。在市場上，疫苗的銷售管道包括獸醫院和診所、獸藥店、普通藥局、電商平台、政府和公共衛生項目、畜牧場和合作社以及其他管道。畜牧業生產的擴張、寵物飼養量的增加、通用感染疾病預防意識的提高以及政府疾病控制計畫的實施，是推動各地區市場擴張的主要因素。

畜牧業生產規模擴大和對動物性蛋白質的需求不斷成長

全球畜牧業生產的快速成長和對動物性蛋白質需求的不斷攀升是獸用疫苗市場的主要驅動力。隨著人口成長和飲食結構向高蛋白攝取轉變，畜牧業持續擴張，對動物保健產品的需求也顯著增加。疫苗對於維護牲畜健康、提高生產力、保障食品安全至關重要。疾病爆發可能對養殖戶造成巨大的經濟損失，因此疫苗的普及應用也日益重要。新興市場的畜牧業正在蓬勃發展，創造了新的機會。隨著全球畜牧業為滿足食品需求而不斷發展，對獸用疫苗的需求持續成長，從而推動了市場的強勁擴張。

疫苗研發高成本且監管要求嚴格

動物疫苗研發所需的大量投資以及複雜的法規核准流程是限制動物疫苗市場發展的主要因素。疫苗研發和臨床試驗都需要大量的資金和時間。各國法規核准流程各不相同，導致合規難度和成本增加。疫苗分銷過程中對低溫運輸的要求也會增加營運成本。疫苗生產需要專門的設施和品管系統。這些研發和監管成本會阻礙產品創新和市場准入，尤其對於資源有限的中小型生產者而言更是如此。

疫苗技術和新平台的進步

獸用疫苗技術的創新為市場拓展帶來了巨大的機會。重組疫苗、DNA疫苗和RNA疫苗平台能夠開發出更有效、更安全的疫苗。載體疫苗和次單位疫苗具有更高的安全性。耐熱疫苗製劑降低了低溫運輸的要求。反向疫苗學和基因組學方法正在加速疫苗的研發。提供更廣泛保護的多價疫苗正得到更廣泛的應用。隨著疫苗技術的進步，具有更高療效和安全性的新產品正在擴大市場佔有率和目標市場。

對疫苗的猶豫和公眾的擔憂

民眾對疫苗的猶豫日益加劇，以及對疫苗安全性的擔憂，對獸用疫苗市場構成重大威脅。有些畜牧養殖戶可能由於擔心成本、有效性或資訊誤導而不願採用新疫苗。社會上的反疫苗情緒會影響動物疫苗的普及。疫苗佐劑和防腐劑的安全性問題仍然存在。改進生物安全和管理系統等替代方案可能會優先考慮。缺乏關於疫苗益處的宣傳也會阻礙疫苗的推廣。這些認知方面的挑戰可能會減緩某些地區和細分市場的成長。

新型冠狀病毒（COVID-19）的影響：

新冠感染疾病對動物疫苗市場產生了重大影響。初期衝擊包括供應鏈中斷、獸醫診所就診量下降、資源轉向人類疫苗研發。疫情期間，疫苗產能受限影響了供應。然而，疫情也可能提高了人們對通用感染疾病和預防醫學的認知，從而加速了疫苗的普及。政府對疫苗生產的支持力道也隨之加大。疫情封鎖期間寵物飼養量的增加催生了新的客戶群。疫情後，由於人們對疾病預防的關注度提高以及對疫苗的認知增強，疫苗需求得以維持，牲畜和伴侶動物疫苗市場均持續成長。

在預測期內，注射劑藥物細分市場預計將佔據最大的市場佔有率。

預計在預測期內，注射疫苗將佔據最大的市場佔有率，這主要得益於其可靠性、精準的劑量控制以及在大多數動物物種中卓越的免疫反應。注射疫苗可透過皮下、肌肉或皮內途徑給藥，從而實現精準的劑量控制和穩定的免疫反應。該領域已廣泛應用於所有動物物種和疫苗類別。成熟的給藥方法和現有的獸醫基礎設施為其持續應用提供了保障。注射疫苗具有免疫反應可靠和疫苗供應充足等優勢。由於其在所有動物物種和獸醫實踐中的廣泛應用，注射疫苗保持最大的市場佔有率。

預計在預測期內，「電子商務平台」細分市場將實現最高的複合年成長率。

在預測期內，電子商務平台細分市場預計將呈現最高的成長率，這主要得益於在線零售的日益普及、直接送貨上門的便利性以及消費者對在線購買寵物和牲畜產品的抵觸情緒的降低。電子商務平台提供便利的購物體驗、具競爭力的價格以及更廣泛的產品選擇。網際網路普及率的提高和數位支付系統的廣泛應用也推動了市場成長。對於那些難以前往動物用藥品店的飼主和養殖戶而言，宅配服務極具吸引力。隨著線上零售在動物保健領域的日益普及，電子商務正在成為所有分銷管道中成長最快的管道。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其完善的獸醫基礎設施、較高的寵物擁有率和蓬勃發展的畜牧業。美國是領先的市場，擁有全面的獸醫服務。高額的寵物醫療費用支出和便利的獸醫院服務是推動市場成長的主要動力。成熟的獸用疫苗生產商佔據重要的市場佔有率。健全的法規結構確保了產品品質和安全。憑藉高寵物擁有率和龐大的畜牧業，北美在市場中保持主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於畜牧業生產的快速擴張、寵物擁有率的上升以及中國、印度和東南亞等國家獸醫基礎設施的不斷完善。收入的成長正在推動寵物擁有率和獸醫支出的增加。畜牧業的成長催生了對疾病預防的需求。政府的動物健康計畫正在促進疫苗的推廣應用。人們對獸醫保健益處的認知不斷提高，正在擴大目標市場。隨著獸醫基礎設施的完善和疫苗推廣應用的推進，亞太地區正經歷全球成長最快的獸用疫苗市場之一。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球獸用疫苗市場：依動物類型分類

  • 家畜
    • 牛
    • 家禽
    • 豬
    • 綿羊和山羊
    • 水產養殖物種
    • 其他牲畜
  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 鳥
    • 其他伴侶動物

第6章：全球獸用疫苗市場：依疫苗類型分類

  • 減毒活疫苗
  • 去活化疫苗
  • 重組疫苗
  • DNA疫苗
  • 載體疫苗
  • 次單位疫苗
  • 類毒素疫苗
  • 結合疫苗
  • 其他疫苗類型

第7章 全球獸用疫苗市場：依疾病適應症分類

  • 口蹄疫
  • 狂犬病
  • 新城疫
  • 禽流感
  • 牛呼吸道疾病（BRD）
  • 豬環狀病毒病（PCV）
  • 經典型豬瘟（CSF）
  • 犬瘟熱
  • 犬小病毒
  • 貓白血病病毒（FeLV）
  • 法氏囊傳染性疾病（IBD）
  • 馬立克氏症
  • 其他疾病指徵

第8章：全球獸用疫苗市場：依給藥途徑分類

  • 注射藥物
  • 口服
  • 鼻內給藥
  • 眼睛
  • 噴霧接種
  • 其他給藥途徑

第9章：全球獸用疫苗市場：依通路分類

  • 獸醫醫院和診所
  • 動物用藥品
  • 零售藥房
  • 電子商務平台
  • 政府和公共衛生項目
  • 畜牧場和合作社
  • 其他分銷管道

第10章：全球獸用疫苗市場：依最終用戶分類

  • 動物醫院
  • 動物診所
  • 畜牧場
  • 家禽養殖場
  • 養豬場
  • 水產養殖場
  • 動物收容所和救援組織
  • 研究機構和大學
  • 其他最終用戶

第11章 全球獸用疫苗市場：依技術平台分類

  • 傳統疫苗技術
  • 重組技術
  • 基因工程技術
  • 基於細胞培養的技術
  • mRNA疫苗技術
  • 基於奈米技術的疫苗
  • 其他技術平台

第12章 全球獸用疫苗市場：依病原體類型分類

  • 病毒疫苗
  • 細菌疫苗
  • 寄生蟲疫苗
  • 真菌疫苗
  • 聯合疫苗

第13章 全球獸用疫苗市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第14章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第15章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品上市及法規核准
  • 擴大生產能力和投資
  • 其他策略舉措

第16章：公司簡介

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale
  • Virbac SA
  • HIPRA
  • Phibro Animal Health Corporation
  • Vetoquinol SA
  • Biogenesis Bago SA
  • Indian Immunologicals Limited
  • Hester Biosciences Limited
  • Dechra Pharmaceuticals PLC
  • Neogen Corporation
  • CZ Vaccines SAU
  • KM Biologics Co., Ltd.
  • Agrovet Market SA
  • Biovac Ltd.
Product Code: SMRC38416

According to Stratistics MRC, the Global Veterinary Vaccines Market is accounted for $13.9 billion in 2026 and is expected to reach $25.4 billion by 2034 growing at a CAGR of 7.8% during the forecast period. Veterinary vaccines are biological preparations administered to animals to stimulate immune responses against specific pathogens, protecting against infectious diseases. These vaccines are administered through various routes including injectable, oral, intranasal, ocular, spray vaccination, and other routes, serving companion animals and livestock across multiple species. The market distributes vaccines through veterinary hospitals and clinics, veterinary pharmacies, retail pharmacies, e-commerce platforms, government and public health programs, livestock farms and cooperatives, and other channels. Growing livestock production, increasing pet ownership, rising awareness of zoonotic disease prevention, and government disease control programs are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Increasing livestock production and demand for animal protein

The rapid growth in global livestock production and rising demand for animal protein are primary drivers for the veterinary vaccines market. As populations grow and diets shift toward higher protein consumption, livestock production continues expanding, creating substantial demand for animal health products. Vaccines are essential for maintaining herd health, improving productivity, and ensuring food safety. Disease outbreaks can cause significant economic losses for farmers, driving vaccine adoption. Emerging markets are expanding livestock production, creating new opportunities. As the global livestock sector grows to meet food demand, demand for veterinary vaccines continues rising, sustaining strong market expansion.

Restraint:

High vaccine development costs and regulatory requirements

The significant investment required for veterinary vaccine development and complex regulatory approval processes represent a major restraint for the veterinary vaccines market. Vaccine research, development, and clinical trials require substantial financial resources and time. Regulatory approval processes vary across countries, creating compliance complexity and costs. Maintaining cold chain requirements for vaccine distribution adds operational costs. Vaccine production requires specialized facilities and quality control systems. These development and regulatory costs may limit product innovation and market entry, particularly for smaller manufacturers with constrained resources.

Opportunity:

Advancements in vaccine technology and novel platforms

Innovations in veterinary vaccine technology present significant opportunities for market expansion. Recombinant, DNA, and RNA vaccine platforms are enabling development of more effective and safer vaccines. Vector-based and subunit vaccines offer improved safety profiles. Thermostable vaccine formulations reduce cold chain requirements. Reverse vaccinology and genomic approaches are accelerating vaccine development. Multi-valent vaccines providing broader protection are gaining adoption. As vaccine technologies advance, new products with enhanced efficacy and safety capture growing market share, expanding the addressable market.

Threat:

Vaccine hesitancy and public perception concerns

Growing vaccine hesitancy and public perception concerns about vaccine safety pose significant threats to the veterinary vaccines market. Some livestock producers may be reluctant to adopt new vaccines due to cost, efficacy concerns, or misinformation. Anti-vaccine sentiment in society can affect animal vaccine adoption. Safety concerns regarding vaccine adjuvants and preservatives persist. Alternative approaches including improved biosecurity and management may be preferred. Communication gaps about vaccine benefits can limit adoption. These perception challenges may slow growth in some regions and market segments.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the veterinary vaccines market. Initial disruptions included supply chain interruptions, reduced veterinary visits, and resource reallocation to human vaccine development. Vaccine production capacity constraints affected supply during the pandemic. However, the pandemic increased awareness of zoonotic diseases and preventive health, potentially benefiting vaccine adoption. Government support for vaccine production expanded. Pet ownership increased during lockdowns, creating new customers. Post-pandemic, heightened focus on disease prevention and vaccine awareness has sustained demand, with continued growth across livestock and companion animal segments.

The Injectable segment is expected to be the largest during the forecast period

The Injectable segment is expected to account for the largest market share during the forecast period, driven by its reliability, precise dosing, and superior immune response in most animal species. Injectable vaccines are administered through subcutaneous, intramuscular, or intradermal routes, enabling precise dosing and consistent immune response. The segment is widely used across all animal types and vaccine categories. Established application methods and existing veterinary infrastructure support continued use. The segment benefits from reliable immune responses and broad vaccine availability. With widespread adoption across all animal types and veterinary practices, injectable vaccines maintain the largest market share.

The E-commerce Platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the E-commerce Platforms segment is predicted to witness the highest growth rate, fueled by the growing adoption of online retail, convenience of direct-to-consumer delivery, and increasing comfort with purchasing pet and livestock products online. E-commerce platforms offer convenience, competitive pricing, and access to a broader product range. Expanding internet penetration and digital payment systems support market growth. Home delivery services appeal to pet owners and farmers with limited access to veterinary pharmacies. As online retail adoption continues growing across animal health, e-commerce delivers the fastest distribution channel growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by established veterinary healthcare infrastructure, high pet ownership, and strong livestock industry. The United States is a major market with comprehensive veterinary services. High pet healthcare spending and veterinary clinic access support market growth. Established veterinary vaccine manufacturers have significant presence. Strong regulatory framework ensures product quality and safety. With high pet ownership and livestock production, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly growing livestock production, increasing pet ownership, and expanding veterinary healthcare infrastructure across countries including China, India, and Southeast Asia. Rising incomes drive increased pet ownership and veterinary care spending. Growing livestock sectors create demand for disease prevention. Government animal health programs support vaccine adoption. Increasing awareness of veterinary healthcare benefits expands the addressable market. As veterinary healthcare infrastructure grows and adoption increases, Asia Pacific delivers the fastest veterinary vaccines market growth globally.

Key players in the market

Some of the key players in Veterinary Vaccines Market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac S.A., HIPRA, Phibro Animal Health Corporation, Vetoquinol S.A., Biogenesis Bago S.A., Indian Immunologicals Limited, Hester Biosciences Limited, Dechra Pharmaceuticals PLC, Neogen Corporation, CZ Vaccines S.A.U., KM Biologics Co., Ltd., Agrovet Market S.A., and Biovac Ltd.

Key Developments:

In July 2026, Zoetis received European Commission marketing authorization for Poulvac(R) Procerta(R) HVT-ND, a live recombinant vector vaccine designed to protect chickens against Newcastle disease and Marek's disease with a single dose administered in ovo or at hatch.

In June 2026, Merck Animal Health announced the acquisition of TARGAN, Inc., a biotechnology company specializing in high-speed, automated targeted delivery systems for poultry and aquaculture vaccination.

In June 2026, Elanco announced the establishment of Elanco Ventures, backed by a $25 million multi-year commitment to fund early-stage startups working on next-generation veterinary therapeutics, vaccines, and One Health solutions.

In December 2025, Merck Animal Health received S&P Global's Best Product Companion Animal and Best Product Food Animal awards for its NUMELVI(TM) and INNOVAX(R) ND-IBD-ILT biological and therapeutic portfolios.

Animal Types Covered:

  • Livestock Animals
  • Companion Animals

Vaccine Types Covered:

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
  • Vector-Based Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Other Vaccine Types

Disease Indications Covered:

  • Foot-and-Mouth Disease (FMD)
  • Rabies
  • Newcastle Disease
  • Avian Influenza
  • Bovine Respiratory Disease (BRD)
  • Porcine Circovirus Disease (PCV)
  • Classical Swine Fever (CSF)
  • Canine Distemper
  • Canine Parvovirus
  • Feline Leukemia Virus (FeLV)
  • Infectious Bursal Disease (IBD)
  • Marek's Disease
  • Other Disease Indications

Routes of Administration Covered:

  • Injectable
  • Oral
  • Intranasal
  • Ocular
  • Spray Vaccination
  • Other Routes of Administration

Distribution Channels Covered:

  • Veterinary Hospitals and Clinics
  • Veterinary Pharmacies
  • Retail Pharmacies
  • E-commerce Platforms
  • Government and Public Health Programs
  • Livestock Farms and Cooperatives
  • Other Distribution Channels

End Users Covered:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Livestock Farms
  • Poultry Farms
  • Swine Farms
  • Aquaculture Farms
  • Animal Shelters and Rescue Organizations
  • Research Institutes and Universities
  • Other End Users

Technology Platforms Covered:

  • Conventional Vaccine Technology
  • Recombinant Technology
  • Genetic Engineering Technology
  • Cell Culture-Based Technology
  • mRNA Vaccine Technology
  • Nanotechnology-Based Vaccines
  • Other Technology Platforms

Pathogen Types Covered:

  • Viral Vaccines
  • Bacterial Vaccines
  • Parasitic Vaccines
  • Fungal Vaccines
  • Combination Vaccines

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Vaccines Market, By Animal Type

  • 5.1 Livestock Animals
    • 5.1.1 Cattle
    • 5.1.2 Poultry
    • 5.1.3 Swine
    • 5.1.4 Sheep and Goats
    • 5.1.5 Aquaculture Species
    • 5.1.6 Other Livestock Animals
  • 5.2 Companion Animals
    • 5.2.1 Dogs
    • 5.2.2 Cats
    • 5.2.3 Horses
    • 5.2.4 Birds
    • 5.2.5 Other Companion Animals

6 Global Veterinary Vaccines Market, By Vaccine Type

  • 6.1 Live Attenuated Vaccines
  • 6.2 Inactivated Vaccines
  • 6.3 Recombinant Vaccines
  • 6.4 DNA Vaccines
  • 6.5 Vector-Based Vaccines
  • 6.6 Subunit Vaccines
  • 6.7 Toxoid Vaccines
  • 6.8 Conjugate Vaccines
  • 6.9 Other Vaccine Types

7 Global Veterinary Vaccines Market, By Disease Indication

  • 7.1 Foot-and-Mouth Disease (FMD)
  • 7.2 Rabies
  • 7.3 Newcastle Disease
  • 7.4 Avian Influenza
  • 7.5 Bovine Respiratory Disease (BRD)
  • 7.6 Porcine Circovirus Disease (PCV)
  • 7.7 Classical Swine Fever (CSF)
  • 7.8 Canine Distemper
  • 7.9 Canine Parvovirus
  • 7.10 Feline Leukemia Virus (FeLV)
  • 7.11 Infectious Bursal Disease (IBD)
  • 7.12 Marek's Disease
  • 7.13 Other Disease Indications

8 Global Veterinary Vaccines Market, By Route of Administration

  • 8.1 Injectable
  • 8.2 Oral
  • 8.3 Intranasal
  • 8.4 Ocular
  • 8.5 Spray Vaccination
  • 8.6 Other Routes of Administration

9 Global Veterinary Vaccines Market, By Distribution Channel

  • 9.1 Veterinary Hospitals and Clinics
  • 9.2 Veterinary Pharmacies
  • 9.3 Retail Pharmacies
  • 9.4 E-commerce Platforms
  • 9.5 Government and Public Health Programs
  • 9.6 Livestock Farms and Cooperatives
  • 9.7 Other Distribution Channels

10 Global Veterinary Vaccines Market, By End User

  • 10.1 Veterinary Hospitals
  • 10.2 Veterinary Clinics
  • 10.3 Livestock Farms
  • 10.4 Poultry Farms
  • 10.5 Swine Farms
  • 10.6 Aquaculture Farms
  • 10.7 Animal Shelters and Rescue Organizations
  • 10.8 Research Institutes and Universities
  • 10.9 Other End Users

11 Global Veterinary Vaccines Market, By Technology Platform

  • 11.1 Conventional Vaccine Technology
  • 11.2 Recombinant Technology
  • 11.3 Genetic Engineering Technology
  • 11.4 Cell Culture-Based Technology
  • 11.5 mRNA Vaccine Technology
  • 11.6 Nanotechnology-Based Vaccines
  • 11.7 Other Technology Platforms

12 Global Veterinary Vaccines Market, By Pathogen Type

  • 12.1 Viral Vaccines
  • 12.2 Bacterial Vaccines
  • 12.3 Parasitic Vaccines
  • 12.4 Fungal Vaccines
  • 12.5 Combination Vaccines

13 Global Veterinary Vaccines Market, By Geography

  • 13.1 North America
    • 13.1.1 United States
    • 13.1.2 Canada
    • 13.1.3 Mexico
  • 13.2 Europe
    • 13.2.1 United Kingdom
    • 13.2.2 Germany
    • 13.2.3 France
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Netherlands
    • 13.2.7 Belgium
    • 13.2.8 Sweden
    • 13.2.9 Switzerland
    • 13.2.10 Poland
    • 13.2.11 Rest of Europe
  • 13.3 Asia Pacific
    • 13.3.1 China
    • 13.3.2 Japan
    • 13.3.3 India
    • 13.3.4 South Korea
    • 13.3.5 Australia
    • 13.3.6 Indonesia
    • 13.3.7 Thailand
    • 13.3.8 Malaysia
    • 13.3.9 Singapore
    • 13.3.10 Vietnam
    • 13.3.11 Rest of Asia Pacific
  • 13.4 South America
    • 13.4.1 Brazil
    • 13.4.2 Argentina
    • 13.4.3 Colombia
    • 13.4.4 Chile
    • 13.4.5 Peru
    • 13.4.6 Rest of South America
  • 13.5 Rest of the World (RoW)
    • 13.5.1 Middle East
      • 13.5.1.1 Saudi Arabia
      • 13.5.1.2 United Arab Emirates
      • 13.5.1.3 Qatar
      • 13.5.1.4 Israel
      • 13.5.1.5 Rest of Middle East
    • 13.5.2 Africa
      • 13.5.2.1 South Africa
      • 13.5.2.2 Egypt
      • 13.5.2.3 Morocco
      • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

  • 14.1 Industry Value Network and Supply Chain Assessment
  • 14.2 White-Space and Opportunity Mapping
  • 14.3 Product Evolution and Market Life Cycle Analysis
  • 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

  • 15.1 Mergers and Acquisitions
  • 15.2 Partnerships, Alliances, and Joint Ventures
  • 15.3 New Product Launches and Regulatory Approvals
  • 15.4 Capacity Expansion and Investments
  • 15.5 Other Strategic Initiatives

16 Company Profiles

  • 16.1 Zoetis Inc.
  • 16.2 Merck Animal Health
  • 16.3 Boehringer Ingelheim Animal Health
  • 16.4 Elanco Animal Health Incorporated
  • 16.5 Ceva Sante Animale
  • 16.6 Virbac S.A.
  • 16.7 HIPRA
  • 16.8 Phibro Animal Health Corporation
  • 16.9 Vetoquinol S.A.
  • 16.10 Biogenesis Bago S.A.
  • 16.11 Indian Immunologicals Limited
  • 16.12 Hester Biosciences Limited
  • 16.13 Dechra Pharmaceuticals PLC
  • 16.14 Neogen Corporation
  • 16.15 CZ Vaccines S.A.U.
  • 16.16 KM Biologics Co., Ltd.
  • 16.17 Agrovet Market S.A.
  • 16.18 Biovac Ltd.

List of Tables

  • Table 1 Global Veterinary Vaccines Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Veterinary Vaccines Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 3 Global Veterinary Vaccines Market Outlook, By Livestock Animals (2023-2034) ($MN)
  • Table 4 Global Veterinary Vaccines Market Outlook, By Cattle (2023-2034) ($MN)
  • Table 5 Global Veterinary Vaccines Market Outlook, By Poultry (2023-2034) ($MN)
  • Table 6 Global Veterinary Vaccines Market Outlook, By Swine (2023-2034) ($MN)
  • Table 7 Global Veterinary Vaccines Market Outlook, By Sheep and Goats (2023-2034) ($MN)
  • Table 8 Global Veterinary Vaccines Market Outlook, By Aquaculture Species (2023-2034) ($MN)
  • Table 9 Global Veterinary Vaccines Market Outlook, By Other Livestock Animals (2023-2034) ($MN)
  • Table 10 Global Veterinary Vaccines Market Outlook, By Companion Animals (2023-2034) ($MN)
  • Table 11 Global Veterinary Vaccines Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 12 Global Veterinary Vaccines Market Outlook, By Cats (2023-2034) ($MN)
  • Table 13 Global Veterinary Vaccines Market Outlook, By Horses (2023-2034) ($MN)
  • Table 14 Global Veterinary Vaccines Market Outlook, By Birds (2023-2034) ($MN)
  • Table 15 Global Veterinary Vaccines Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • Table 16 Global Veterinary Vaccines Market Outlook, By Vaccine Type (2023-2034) ($MN)
  • Table 17 Global Veterinary Vaccines Market Outlook, By Live Attenuated Vaccines (2023-2034) ($MN)
  • Table 18 Global Veterinary Vaccines Market Outlook, By Inactivated Vaccines (2023-2034) ($MN)
  • Table 19 Global Veterinary Vaccines Market Outlook, By Recombinant Vaccines (2023-2034) ($MN)
  • Table 20 Global Veterinary Vaccines Market Outlook, By DNA Vaccines (2023-2034) ($MN)
  • Table 21 Global Veterinary Vaccines Market Outlook, By Vector-Based Vaccines (2023-2034) ($MN)
  • Table 22 Global Veterinary Vaccines Market Outlook, By Subunit Vaccines (2023-2034) ($MN)
  • Table 23 Global Veterinary Vaccines Market Outlook, By Toxoid Vaccines (2023-2034) ($MN)
  • Table 24 Global Veterinary Vaccines Market Outlook, By Conjugate Vaccines (2023-2034) ($MN)
  • Table 25 Global Veterinary Vaccines Market Outlook, By Other Vaccine Types (2023-2034) ($MN)
  • Table 26 Global Veterinary Vaccines Market Outlook, By Disease Indication (2023-2034) ($MN)
  • Table 27 Global Veterinary Vaccines Market Outlook, By Foot-and-Mouth Disease (FMD) (2023-2034) ($MN)
  • Table 28 Global Veterinary Vaccines Market Outlook, By Rabies (2023-2034) ($MN)
  • Table 29 Global Veterinary Vaccines Market Outlook, By Newcastle Disease (2023-2034) ($MN)
  • Table 30 Global Veterinary Vaccines Market Outlook, By Avian Influenza (2023-2034) ($MN)
  • Table 31 Global Veterinary Vaccines Market Outlook, By Bovine Respiratory Disease (BRD) (2023-2034) ($MN)
  • Table 32 Global Veterinary Vaccines Market Outlook, By Porcine Circovirus Disease (PCV) (2023-2034) ($MN)
  • Table 33 Global Veterinary Vaccines Market Outlook, By Classical Swine Fever (CSF) (2023-2034) ($MN)
  • Table 34 Global Veterinary Vaccines Market Outlook, By Canine Distemper (2023-2034) ($MN)
  • Table 35 Global Veterinary Vaccines Market Outlook, By Canine Parvovirus (2023-2034) ($MN)
  • Table 36 Global Veterinary Vaccines Market Outlook, By Feline Leukemia Virus (FeLV) (2023-2034) ($MN)
  • Table 37 Global Veterinary Vaccines Market Outlook, By Infectious Bursal Disease (IBD) (2023-2034) ($MN)
  • Table 38 Global Veterinary Vaccines Market Outlook, By Marek's Disease (2023-2034) ($MN)
  • Table 39 Global Veterinary Vaccines Market Outlook, By Other Disease Indications (2023-2034) ($MN)
  • Table 40 Global Veterinary Vaccines Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 41 Global Veterinary Vaccines Market Outlook, By Injectable (2023-2034) ($MN)
  • Table 42 Global Veterinary Vaccines Market Outlook, By Oral (2023-2034) ($MN)
  • Table 43 Global Veterinary Vaccines Market Outlook, By Intranasal (2023-2034) ($MN)
  • Table 44 Global Veterinary Vaccines Market Outlook, By Ocular (2023-2034) ($MN)
  • Table 45 Global Veterinary Vaccines Market Outlook, By Spray Vaccination (2023-2034) ($MN)
  • Table 46 Global Veterinary Vaccines Market Outlook, By Other Routes of Administration (2023-2034) ($MN)
  • Table 47 Global Veterinary Vaccines Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 48 Global Veterinary Vaccines Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • Table 49 Global Veterinary Vaccines Market Outlook, By Veterinary Pharmacies (2023-2034) ($MN)
  • Table 50 Global Veterinary Vaccines Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 51 Global Veterinary Vaccines Market Outlook, By E-commerce Platforms (2023-2034) ($MN)
  • Table 52 Global Veterinary Vaccines Market Outlook, By Government and Public Health Programs (2023-2034) ($MN)
  • Table 53 Global Veterinary Vaccines Market Outlook, By Livestock Farms and Cooperatives (2023-2034) ($MN)
  • Table 54 Global Veterinary Vaccines Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 55 Global Veterinary Vaccines Market Outlook, By End User (2023-2034) ($MN)
  • Table 56 Global Veterinary Vaccines Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
  • Table 57 Global Veterinary Vaccines Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 58 Global Veterinary Vaccines Market Outlook, By Livestock Farms (2023-2034) ($MN)
  • Table 59 Global Veterinary Vaccines Market Outlook, By Poultry Farms (2023-2034) ($MN)
  • Table 60 Global Veterinary Vaccines Market Outlook, By Swine Farms (2023-2034) ($MN)
  • Table 61 Global Veterinary Vaccines Market Outlook, By Aquaculture Farms (2023-2034) ($MN)
  • Table 62 Global Veterinary Vaccines Market Outlook, By Animal Shelters and Rescue Organizations (2023-2034) ($MN)
  • Table 63 Global Veterinary Vaccines Market Outlook, By Research Institutes and Universities (2023-2034) ($MN)
  • Table 64 Global Veterinary Vaccines Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 65 Global Veterinary Vaccines Market Outlook, By Technology Platform (2023-2034) ($MN)
  • Table 66 Global Veterinary Vaccines Market Outlook, By Conventional Vaccine Technology (2023-2034) ($MN)
  • Table 67 Global Veterinary Vaccines Market Outlook, By Recombinant Technology (2023-2034) ($MN)
  • Table 68 Global Veterinary Vaccines Market Outlook, By Genetic Engineering Technology (2023-2034) ($MN)
  • Table 69 Global Veterinary Vaccines Market Outlook, By Cell Culture-Based Technology (2023-2034) ($MN)
  • Table 70 Global Veterinary Vaccines Market Outlook, By mRNA Vaccine Technology (2023-2034) ($MN)
  • Table 71 Global Veterinary Vaccines Market Outlook, By Nanotechnology-Based Vaccines (2023-2034) ($MN)
  • Table 72 Global Veterinary Vaccines Market Outlook, By Other Technology Platforms (2023-2034) ($MN)
  • Table 73 Global Veterinary Vaccines Market Outlook, By Pathogen Type (2023-2034) ($MN)
  • Table 74 Global Veterinary Vaccines Market Outlook, By Viral Vaccines (2023-2034) ($MN)
  • Table 75 Global Veterinary Vaccines Market Outlook, By Bacterial Vaccines (2023-2034) ($MN)
  • Table 76 Global Veterinary Vaccines Market Outlook, By Parasitic Vaccines (2023-2034) ($MN)
  • Table 77 Global Veterinary Vaccines Market Outlook, By Fungal Vaccines (2023-2034) ($MN)
  • Table 78 Global Veterinary Vaccines Market Outlook, By Combination Vaccines (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.